As of 06 Nov 2026 03:14 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2024/074 (19 Jun 2024): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Flixotide® (fluticasone) 125micrograms/dose and 250micrograms/dose Evohaler®affected product · inferred from phrasing | Out of stock, as stated | mid-July 2024precision: mid-month · window end 20 Jul 2024, derived from “mid-July 2024” | notice of 19 Jun 2024 |
| Flixotide® (fluticasone) Accuhaler® 100microgram, 250microgram and 500microgramnamed by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 19 Jun 2024 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Flixotide® (fluticasone) Accuhaler® 100microgram, 250microgram and 500microgram — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Flixotide
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
Notified short 3 times on record since 2021 — a recurring shortage spanning 3.1 years. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 19 Jun 2024 | Medicine Supply Notification: Flixotide® (fluticasone) 125micrograms/dose and 250micrograms/dose Evohaler® | Supply notification | Tier 2 | MSN/2024/074 |
| 08 Feb 2024 | Medicine Supply Notification: Flixotide® (fluticasone) 50 micrograms/dose Evohaler | Supply notification | Tier 2 | MSN/2024/014 |
| 11 May 2021 | Medicine Supply Notification: Flixotide® (fluticasone propionate) 100 microgram Accuhaler - Update | Supply notification | Tier 2 | MSN/2021/025 |
Also recorded under
Bracketed names seen in this medicine's notice titles: fluticasone, fluticasone propionate. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2020)90 Fluticasone propionate (Flixotide®) 0.5mg/2ml and 2mg/2ml Nebules · issued 29 Sep 2020 · valid until Mid-February 2021, as stated · matched by name PDF ↗
- MSAN(2020)73 Fluticasone propionate (Flixotide®) 0.5mg/2ml and 2mg/2ml Nebules · issued 27 Jul 2020 · valid until Mid-December 2020, as stated · matched by name PDF ↗
- MSAN(2020)64 Fluticasone propionate (Flixotide®) 0.5mg/2ml and 2mg/2ml Nebules · issued 30 Jun 2020 · valid until 4 November 2020, as stated · matched by name PDF ↗